|
|
Volumn 255, Issue 8, 2008, Pages 1272-1273
|
|
Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1A INTERFERON;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
MITOXANTRONE;
NATALIZUMAB;
RITUXIMAB;
ADULT;
BRAIN BIOPSY;
BRAIN DAMAGE;
CASE REPORT;
CEREBROSPINAL FLUID ANALYSIS;
CLINICAL FEATURE;
DRUG DOSE INCREASE;
EPILEPTIC STATE;
FAMILY HISTORY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LETTER;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PLASMAPHERESIS;
PRIORITY JOURNAL;
REMISSION;
SINGLE DRUG DOSE;
STUPOR;
ADULT;
ANTIGENS, CD13;
CALGRANULIN B;
DEMYELINATING DISEASES;
FEMALE;
HUMANS;
MACROPHAGES;
MAGNETIC RESONANCE IMAGING;
MULTIPLE SCLEROSIS;
MYELIN-ASSOCIATED GLYCOPROTEIN;
|
|
EID: 60049087269
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-0883-x Document Type: Letter |
|
Times cited : (19)
|
|
References (8)
|
